App-Quantinova.ai

Final 5-Year Results in Unselected Patients Implanted With a Thin-Strut, Platinum-Chromium, Everolimus-Eluting Stent: The PROMUS Element Plus US Post-Approval Study

David Kandzari - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

Promus Element

Long-Term Impact of Improving Drug-Eluting Stent Technology in Patients Undergoing Multilesion Intervention: A Patient-Level Analysis of 19 Randomized Trials

Paul Guedeney - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Results of percutaneous coronary intervention with second-generation paclitaxel coated balloons in diabetic patients at a long-term follow-up.

Jose Abellan-Huerta - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

Paclitaxel

Direct Stenting Strategy is Associated with Improved Survival in Women Undergoing Primary Percutaneous Coronary Intervention for ST-elevation Myocardial Infarction: A Propensity Score Matched Comparative Study

Ivan Bessonov - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Comparative safety and effectiveness of polymer-free biolimus-eluting stents versus permanent-polymer everolimus-eluting stents in routine clinical practice

Arturo Giordano - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

Everolimus

Clinical Outcomes of Hemodialysis Patients With Coronary Artery Disease After Newer Generation Drug-Eluting Stent Implantation

Shota Okuno - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

The Comparative Effectiveness and Safety of Cangrelor vs. In- lab Glycoprotein IIb/IIIa Inhibitor (GPI) in Patients Undergoing Percutaneous Coronary Intervention: Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2)

Saifullah Siddiqui - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

cangrelor

Use of New Thienopyridines in Patients with Coronary Artery Disease Treated with Percutaneous Coronary Interventions in Argentina. Results From A “Real World” Multicenter Registry

Alfredo Rodriguez Granillo - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Rapacan

The Prevalence of Computed Tomography-Defined Leaflet Thrombosis in Intra- versus Supra-Annular Transcatheter Aortic Valve Prostheses

Hashrul Rashid - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Clinical Presentation, Management and Outcomes of Patients who developed Post Transcatheter Aortic Valve Replacement Thrombosis: Global Case Series

Daniel Garcia - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Impact of Drug-Eluting Stent Generation in Elderly Patients Undergoing PCI: Five-Year Follow-up From a Patient-Level Analysis of 19 Randomized Trials

Paul Guedeney - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Magnesium-metallic bioabsorbable scaffold (Magmaris) long-term results. Analysis from pooled multicentre italian experience.

Stefano Galli - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Early Results Following Magnesium Bioresorbable Vascular Scaffold Implantation in Patients with Acute Myocardial Infarction

Alfonso Ielasi - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

sirolimus

Clinical Utility of Combined Optical Coherence Tomography and Near-Infrared Spectroscopy for Assessing the Mechanism of Very Late Stent Thrombosis

Yasushi Ino - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Prevalence and Impact of Bleeding Determinants on Risks for out-of-hospital bleeding and coronary thrombosis in patients undergoing percutaneous coronary intervention: Results from a large single-center PCI Registry

Sabato Sorrentino - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Very Late Stent Thrombosis after Revascularization with Biodegradable Polymer Drug-Eluting Stents. From the SORT OUT VII Trial

Lisette Okkels Jensen - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

sirolimus

Incidence And Predictors Of Outcomes After First Definite Stent Thrombosis Event

Maria Tovar Forero - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Effect of PSP and other Elements of Technique on 3 Year Outcomes Among Metallic Everolimus-Eluting Stent-Treated Patients in the ABSORB Trials

Stephen Ellis - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Everolimus

Duration of dual antiplatelet therapy in elective drug coated balloon angioplasty

Natasha Corballis - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Duration of dual antiplatelet therapy after drug-coated balloon implantation

Franz Kleber - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Filters

7277 Abstracts